Evista (Raloxifene)

This is a medicine called Evista. It's used to help prevent bone loss in women after they go through menopause. It works by mimicking estrogen's effect on bones, helping to keep them strong. It's taken as a pill.

Brand names:Evista
Medication

What people taking Evista (Raloxifene) report

Every report comes from a Lived member, sent anonymously.

Have you tried Evista (Raloxifene) for Postmenopausal Osteoporosis?

NameHow it went

About Evista (Raloxifene)

What It's For

Raloxifene, sold under the brand name Evista and as a generic, is a prescription tablet for women who have gone through menopause. It is used to treat and to prevent osteoporosis, the thinning of bone that makes fractures more likely. It is also approved to lower the chance of developing invasive breast cancer in postmenopausal women who have osteoporosis or who are at high risk of breast cancer, for example because of a close relative with the disease or an earlier biopsy showing abnormal breast cells. For bones, raloxifene's proven benefit is fewer fractures of the spine. It has not been shown to reduce hip fractures or other fractures outside the spine, which is one reason bisphosphonates, the most widely used family of bone-strengthening medicines, are usually recommended first. Raloxifene is often considered when someone also wants breast cancer risk reduction, or cannot take other bone medicines. It does not treat breast cancer, does not prevent a past cancer from coming back, and is not used before menopause or in men.

How It Works

Estrogen helps keep bone strong, which is why bone loss speeds up after menopause. Raloxifene belongs to a group called selective estrogen receptor modulators, or SERMs: it attaches to the same receptors as estrogen, but the effect depends on the tissue. In bone it acts like estrogen, slowing the breakdown of old bone so density holds steady or rises slightly. In breast and uterine tissue it blocks estrogen instead. That blocking effect explains its role in breast cancer prevention, since most breast cancers grow in response to estrogen. Unlike estrogen hormone therapy, it does not stimulate the lining of the uterus or the breasts, but it also does not relieve menopause symptoms.

Dosage & Administration

Raloxifene is one 60 mg tablet taken by mouth once a day, at any time of day, with or without food. Taking it around the same time each day helps with remembering. If a dose is missed, take it when remembered unless the next dose is nearly due; do not take two at once. For osteoporosis, it works alongside enough calcium and vitamin D, from food or supplements, plus weight-bearing exercise and avoiding smoking and heavy drinking. Because being still for long periods raises the risk of blood clots, the label advises stopping raloxifene at least 72 hours (three days) before planned surgery or extended bed rest and restarting only once you are fully up and moving again. On long car or plane trips, get up and move around periodically.

Side Effects

Hot flashes are the most noticeable side effect, especially in the first six months. Raloxifene does not relieve menopausal hot flashes and can bring them on in women who did not have them. Leg cramps, swelling of the feet and ankles, joint aches, flu-like symptoms and sweating are also more common than with a placebo. These are usually mild. The most serious risk is a blood clot, most likely in the first four months. In the main osteoporosis trial, about 1 in 100 women taking raloxifene had a clot over roughly two and a half years. Pain, warmth or new swelling in one calf or leg can signal a clot in a leg vein and should be reported to your clinician right away. Sudden chest pain, shortness of breath or coughing up blood can mean a clot has reached the lungs: call 911. A sudden change or loss of vision needs to be checked the same day. Any vaginal bleeding or new breast change should also be reported, since raloxifene should not cause either.

Interactions & Warnings

Raloxifene carries an FDA boxed warning, the strongest kind, about blood clots and stroke. Anyone who has had a clot in the legs, lungs or the veins of the eye should not take it. In a large trial of postmenopausal women with heart disease or a high chance of heart problems, raloxifene did not raise the number of strokes, but slightly more of the women who had a stroke died from it. People with a past stroke or mini-stroke, atrial fibrillation, high blood pressure or who smoke should weigh this with their clinician. Raloxifene should not be taken to prevent heart disease; it showed no heart benefit. It must not be taken during pregnancy, as it can harm a developing baby, or while breastfeeding. Use is more cautious with liver or kidney disease, after breast cancer (it has not been well studied there), or for anyone whose triglycerides (a blood fat) rose sharply on estrogen in the past. Raloxifene is not combined with estrogen pills or patches. Cholestyramine, a cholesterol-lowering powder, blocks its absorption and should be avoided. People taking warfarin, a blood thinner, need closer checks of their INR (international normalized ratio, a blood test of how long blood takes to clot) when raloxifene is started or stopped, because the warfarin dose may need adjusting.

What to Expect

Raloxifene usually causes nothing you can feel day to day, apart from possible hot flashes or leg cramps. Its bone effect is tracked with periodic bone density scans, typically a DXA scan (a low-dose X-ray that measures bone mineral density), and the goal is fewer fractures rather than a dramatic change in the number. In the main trial, bone density in the spine and hip rose by about 2 to 3%, yet spine fractures fell by roughly half in women without a previous one, more than density alone would predict. Regular mammograms and breast exams continue while on it, because lowering breast cancer risk does not remove it. For breast cancer prevention the best length of treatment is not known; trials ran around five years. Bone treatment is reviewed periodically and may be switched to another medicine if fracture risk rises or side effects matter.

Questions to Ask Your Doctor

  1. 1.Why is raloxifene a better fit for me than a bisphosphonate or another bone medicine, given it has not been shown to prevent hip fractures?
  2. 2.How much would raloxifene lower my breast cancer risk, and how does it compare with tamoxifen or other options?
  3. 3.Does my history of clots, stroke, heart disease or smoking change whether raloxifene is safe for me?
  4. 4.When should I stop it before surgery or travel, and who will tell me when to restart?
  5. 5.How will we check that it is working, and how long should I expect to take it?

Last reviewed • Oct 2026

Educational content, not medical advice.